Intellectual Property Cases
Cases 11 - 20 of 23
Biogen International GmbH et al v. Glenmark Pharmaceuticals Limited et al
as 1:2017cv00852
Plaintiff: Biogen International GmbH and Biogen MA Inc.
Defendant: Glenmark Pharmaceuticals Limited and Glenmark Pharmaceuticals Inc., USA
Cause Of Action: 35 U.S.C. § 271
Biogen International GmbH et al v. Amneal Pharmaceuticals LLC et al. We have downloadable decisions or orders for this case
as 1:2017cv00823
Defendant: TWi Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Sawai Pharmaceutical Co., Ltd. and others
Plaintiff: Biogen International GmbH and Biogen MA Inc.
Cause Of Action: 35 U.S.C. § 271
Upsher-Smith Laboratories, Inc. v. Glenmark Pharmaceuticals Limited et al
as 1:2017cv00649
Plaintiff: Upsher-Smith Laboratories, Inc.
Defendant: Glenmark Pharmaceuticals Limited and Glenmark Pharmaceuticals Inc., USA
Cause Of Action: 35 U.S.C. § 271
NOVO NORDISK INC. et al v. GLENMARK PHARMACEUTICALS LIMITED et al
as 3:2017cv03462
Plaintiff: NOVO NORDISK INC. and NOVO NORDISK HEALTHCARE AG
Defendant: GLENMARK PHARMACEUTICALS LIMITED and GLENMARK PHARMACEUTICALS INC., USA
Cause Of Action: 35 U.S.C. § 271
Sanofi-Aventis U.S. LLC et al v. Glenmark Pharmaceuticals Inc., USA et al
as 1:2016cv01326
Plaintiff: Sanofi-Aventis U.S. LLC , Aventisub LLC , Sanofi and others
Defendant: Glenmark Pharmaceuticals Inc., USA and Glenmark Pharmaceuticals SA
Cause Of Action: 35 U.S.C. § 271
ASTRAZENECA AB et al v. GLENMARK PHARMACEUTICALS LTD. et al
as 3:2016cv07330
Plaintiff: ASTRAZENECA AB , AKTIEBOLAGET HASSLE , ASTRAZENECA LP and others
Defendant: GLENMARK PHARMACEUTICALS LTD., GLENMARK PHARMACEUTICALS SA and GLENMARK PHARMACEUTICALS INC., USA
Cause Of Action: 35 U.S.C. § 271
BTG INTERNATIONAL LIMITED et al v. GLENMARK PHARMACEUTICALS INC., USA et al
as 2:2016cv03743
Plaintiff: BTG INTERNATIONAL LIMITED , JANSSEN BIOTECH, INC. , JANSSEN ONCOLOGY, INC. and others
Defendant: GLENMARK PHARMACEUTICALS INC., USA, GLENMARK PHARMACEUTICALS SA and GLENMARK PHARMACEUTICALS LTD.
Cause Of Action: 15 U.S.C. § 1126
Sanofi et al v. Glenmark Pharmaceuticals Inc. USA et al
as 1:2015cv01206
Plaintiff: Sanofi and Sanofi-Aventis U.S. LLC
Defendant: Glenmark Pharmaceuticals Inc. USA and Glenmark Pharmaceuticals Limited
Counter_claimant: Glenmark Pharmaceuticals Inc. USA and Glenmark Pharmaceuticals Limited
Counter_defendant: Sanofi and Sanofi-Aventis U.S. LLC
Cause Of Action: 35 U.S.C. § 271
SYMED LABS LIMITED et al v. GLENMARK PHARMACEUTICALS INC., USA We have downloadable decisions or orders for this case
as 2:2015cv08306
Plaintiff: SYMED LABS LIMITED and HETERO USA, INC.
Defendant: GLENMARK PHARMACEUTICALS INC., USA
Cause Of Action: 35 U.S.C. § 271
SANOFI-AVENTIS DEUTSCHLAND GMBH et al v. GLENMARK PHARMACEUTICALS INC., USA et al
as 2:2008cv01658
Plaintiff: SANOFI-AVENTIS DEUTSCHLAND GMBH, AVENTIS PHARMA S.A., ABBOTT GMBH & CO. KG and others
Defendant: GLENMARK PHARMACEUTICALS INC., USA and GLENMARK PHARMACEUTICALS LTD.
Cause Of Action: Federal Question

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?